Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML)
Green
C L
CL
Loken
M
M
Buck
D
D
Deeg
H J
HJ
D000071916:AC133 Antigen; D015703:Antigens, CD; D018952:Antigens, CD34 / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis* / Q000235:genetics; D000939:Epitopes / Q000032:analysis / Q000276:immunology; D005434:Flow Cytometry; D015870:Gene Expression; D015973:Gene Expression Regulation, Leukemic; D006023:Glycoproteins / Q000032:analysis* / Q000235:genetics; D006801:Humans; D007951:Leukemia, Myeloid / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D009190:Myelodysplastic Syndromes / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000276:immunology*; D010455:Peptides / Q000032:analysis* / Q000235:genetics
D000071916:AC133 Antigen; D015703:Antigens, CD; D018952:Antigens, CD34; D000951:Antigens, Neoplasm; D000939:Epitopes; D006023:Glycoproteins; C000606023:PROM1 protein, human; D010455:Peptides